Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 22 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

11 trials in Phase 3/4

Results Transparency

17%

2 of 12 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

Phase 3
6(35.3%)
Phase 4
5(29.4%)
N/A
4(23.5%)
Phase 2
2(11.8%)
17Total
Phase 3(6)
Phase 4(5)
N/A(4)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (22)

Showing 20 of 22 trials
NCT07149506Phase 3Enrolling By Invitation

Oral or Topical Catechins for Radiation Dermatitis

Role: collaborator

NCT06291428Recruiting

Raman Spectroscopy Compared to Flow Cytometry

Role: lead

NCT05595447Phase 2Recruiting

Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma

Role: lead

NCT05781243Phase 4Completed

Normal Saline Versus Lactated Ringer's Solution for Acute Pancreatitis Resuscitation

Role: collaborator

NCT05718999Unknown

XGBoost for Predict Incisional Hernia

Role: lead

NCT04134455Not ApplicableCompleted

The Mesh-RTL Project, for Prevention of Incisional Hernia

Role: lead

NCT03019965Not ApplicableCompleted

Efficacy of Betalactam Antibiotics in Prolonged Infusion Compared to Intermittent in Pediatric Patients With Sepsis

Role: collaborator

NCT04819828Phase 4Completed

Tamsulosin as Adjunctive Therapy After Extracorporeal Shock Wave Lithotripsy for Renal Stones

Role: lead

NCT04542213Phase 3Completed

Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19

Role: lead

NCT04559321Phase 3Unknown

Holmium Vs Trilogy Kidney Stones GUY's 1-2

Role: lead

NCT03635970Not ApplicableCompleted

Cell Therapy for Peripheral Arterial Disease and Diabetes

Role: lead

NCT04388410Phase 2Unknown

Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19

Role: collaborator

NCT04311060Unknown

Genetic and Molecular Characteristics of Mexican Adults With Acute Myeloid Leukemia: a Prospective Multicentric Study.

Role: collaborator

NCT04168801Not ApplicableCompleted

Early Oral Refeeding in Mild Acute Pancreatitis

Role: lead

NCT04134650Phase 3Unknown

Effect of Low Dose Combination of Linagliptin + Metformin to Prevent Diabetes

Role: collaborator

NCT04131582Phase 3Unknown

Effect of Empagliflozin + Linagliptin + Metformin + Lifestyle in Patients With Prediabetes

Role: collaborator

NCT04088461Phase 4Completed

Effect of Linagliptin + Metformin on Patients Who do Not Achieve Normoglucemia With Metformine

Role: collaborator

NCT03004612Phase 4Completed

Effect of Linagliptin + Metformin vs Metformin Alone in Patients With Prediabetes

Role: collaborator

NCT03970668Completed

Linagliptin in Post-renal Transplantation

Role: collaborator

NCT02414581Phase 3Completed

Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7%

Role: lead